Drug of Abuse (DOA) Testing Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Drug of Abuse (DOA) Testing Market should grow from $3.5 billion in 2020 to $4.6 billion by 2028 with a compound annual growth rate (CAGR) of 5% for the period of 2022-2028.

Drug of abuse (DOA) testing is a type of diagnostic method that analyzes an individual’s substance or chemical abuse by testing samples such as saliva, blood, hair, breath, and urine. It is primarily used to determine the use of recreational drugs in an individual’s system to provide the correct treatment and clinical procedure.

Market Segments

By Type:

• Urine
• Saliva
• Hair
• Others

By Application:

• Hospitals
• Laboratories
• Workplace
• At-Home

Key Players

Some of the major players are Abbott, Dragerwerk AG & Co. KGaA, UCP Biosciences Inc., Orient New Life Medical Co. Ltd., Assure Tech.(Hangzhou) Co., LTD, Psychemedics Corporation.

Scope of the Report

The research study analyzes the global Drug of Abuse (DOA) Testing industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Drug of Abuse (DOA) Testing Market Report

1. What was the Drug of Abuse (DOA) Testing Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Drug of Abuse (DOA) Testing Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Drug of Abuse (DOA) Testing Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.